Accessibility Menu
EDAP TMS logo

EDAP TMS(NASDAQ) FOCL

Market Cap$161.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-49%
5 Year-27%
1 Year+137%
1 Month-31%
Premium Feature
Moneyball Superscore
68/100
$4.32
+0.23%
+0.01Today
EDAP TMS last closing stock price
MetricPriceDate
Last closeUSD 4.312026-08-28
EDAP TMS stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.36%USD 4.132026-08-21
1 month-31.04%USD 6.252026-07-29
3 month-0.23%USD 4.322026-05-29
Year to date+31%USD 3.292025-12-31
1 year+136.81%USD 1.822025-08-28
3 year-46.72%USD 8.092023-08-29
5 year-26.95%USD 5.902021-08-27
Since inception-49.29%USD 8.501997-08-01

EDAP TMS Financials at a Glance

Market Cap

$161.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$69.14M

Net Income (TTM)

-$38.89M

EPS (TTM)

-$1.04

P/E Ratio

-4.15

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$4.32

Volume

558.437

Open

$4.31

Previous Close

$4.31

Daily Range

$4.31 - $4.32

52-Week Range

$1.75 - $6.40

Estimated Earnings Date

Nov 5, 2026

FOCL News

No articles available.

FOCL: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EDAP TMS

EDAP TMS S.A. helps doctors treat prostate tumors without surgery. It uses high-energy sound waves to destroy diseased tissue robotically. This technology helps patients recover faster from medical treatments.

Robotic Tools and Treatment Services

  • Medical Devices: Robotic systems like Focal One that use ultrasound to target and destroy tumors; generated $13.9 million of revenue in the six months ended June 30, 2026.
  • Treatment-Driven Services: Sales of disposable parts and procedure-based fees for medical treatments; accounted for $9.5 million of revenue in the six months ended June 30, 2026.
  • Urological Equipment: Diagnostic and treatment tools for kidney stones and other disorders; represented approximately 47% of consolidated revenue for the year ended Dec. 31, 2025.

Shifting Toward Robotic Therapy

  • Approved a plan to exit the legacy stone treatment and distribution business lines on May 28, 2026.
  • Announced a strategic rebrand to FocalTherics on May 29, 2026, to focus on robotic therapy.
  • Completed a public offering of American Depositary Shares for $37.1 million on Aug. 14, 2026.
  • Established a credit facility with the European Investment Bank on Oct. 17, 2025.

Precision Through Robotic Systems

EDAP TMS uses High Intensity Focused Ultrasound (HIFU) to provide non-surgical treatment options for localized tumors. Its Focal One platform integrates robotic control to increase the precision of these minimally invasive procedures.

By the Numbers

  • Total revenue reached $13.2 million in the three months ended June 30, 2026, up 38.8% year over year.
  • Gross margin increased to 55.6% during the three months ended June 30, 2026, up from 51.1% in the prior year period.
  • Net loss for the three months ended June 30, 2026, was $14.5 million.
  • Cash and cash equivalents totaled $21.5 million as of June 30, 2026.
  • Marketing and sales expenses rose to $13.8 million in the six months ended June 30, 2026.

Bottom Line

EDAP TMS is transforming into a specialized robotic therapy company by divesting its legacy business lines. Its focus on the Focal One platform marks a strategic shift toward high-growth cancer treatments.

AI Generated • Aug 15, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

289

CEO

Ryan Rhodes

Website

www.focalone.com

Headquarters

Vaulx-en-Velin, ARA 69120, FR

FOCL Financials

Key Financial Metrics (TTM)

Gross Margin

45.98%

Operating Margin

-39.32%

Net Income Margin

-56.25%

Return on Equity

-289.98%

Return on Capital

-53.53%

Return on Assets

-52.17%

Earnings Yield

-24.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$161.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

37.48M

Volume

558.437

Avg. Volume

99.71K

Financials (TTM)

Gross Profit

$31.79M

Operating Income

-$27.19M

EBITDA

-$26.43M

Operating Cash Flow

-$12.90M

Capital Expenditure

-$4.78M

Free Cash Flow

-$17.68M

Cash & ST Invst.

$21.54M

Total Debt

$39.89M

EDAP TMS Performance Analysis

EDAP TMS annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 57,917,09311.2%
20232023-12-31USD 65,324,24812.8%
20242024-12-31USD 69,352,6036.2%
20252025-12-31USD 70,745,2252.0%
EDAP TMS sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-10.8%
Q42025-12-3134.8%
Q12026-03-31-18.2%
Q22026-06-30-26.2%
EDAP TMS annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.09N/A
20232023-12-31USD -0.62590.7%
20242024-12-31USD -0.55-10.9%
20252025-12-31USD -0.7842.0%
EDAP TMS sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-305.9%
Q42025-12-31-56.3%
Q12026-03-314.0%
Q22026-06-30-62.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$13.18M

-27.5%

Gross Profit

$7.33M

-5.2%

Gross Margin

55.58%

N/A

Market Cap

$161.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$558.99K

N/A

Employees

289

N/A

Net Income

-$14.47M

-127.9%

EBITDA

-$8.02M

-29.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$21.54M

+12.9%

Total Debt

$39.89M

+279.8%

Accounts Receivable

$10.06M

-53.7%

Inventory

$8.25M

-54.7%

Long Term Debt

$38.03M

+1109.3%

Short Term Debt

$1.86M

-74.7%

Return on Assets

-52.17%

N/A

Return on Invested Capital

-72.12%

N/A

Free Cash Flow

-$4.95M

+19.0%

Operating Cash Flow

-$3.69M

+21.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,711.76-0.00%
^DJIDJI
$53,559.99-0.00%
^IXICNASDAQ
$26,402.42-0.01%
BTCBitcoin
$78,843.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.09%
NVDANvidia
$219.85+0.01%
AEHLAntelope Enterprise
$6.17+0.74%

Questions About FOCL

What is the current price of EDAP TMS?

EDAP TMS is trading at $4.32 per share.

What is the 52-week range for EDAP TMS?

Over the past 52 weeks, EDAP TMS has traded between $1.75 and $6.40.

How much debt does EDAP TMS have?

As of the most recent reporting period, EDAP TMS reported total debt of $41.68M.

How much cash does EDAP TMS have on hand?

EDAP TMS reported $21.54M in cash and cash equivalents in its most recent financial results.

What is EDAP TMS’s dividend yield?

EDAP TMS does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services